Literature DB >> 365753

Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.

B Björkstén, B Kaijser.   

Abstract

Strains of Escherichia coli isolated from the urine of children with pyelonephritis (n = 18) or asymptomatic bacteriuria (ABU) (n = 20) were serotyped and compared with respect to opsonic requirements, sensitivity to serum, amount of chemiluminescence produced by normal neutrophils during phagocytosis of the various strains, and amount of capsular antigen. Strains isolated from cases of ABU more often had the capacity to activate the alternative complement pathway than had strains causing pyelonephritis. The ABU strains were also better opsonized in fresh human serum and were more often serum sensitive than the pyelonephritic strains. There were individual variations in neutrophil chemiluminescence during phagocytosis of the various strains, but the two groups of strains did not differ significantly. The strains from pyelonephritis cases produced a greater amount of capsular antigens than the ABU strains. There was no correlation between presence of a particular O or K antigen and capacity to activate the alternative complement pathway. The observed differences between strains isolated from patients with ABU and those isolated from patients with pyelonephritis may be relevant for further studies on differences in bacterial virulence or host defense factors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365753      PMCID: PMC422154          DOI: 10.1128/iai.22.2.308-311.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

Review 1.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

2.  On the accuracy of identification of K1 E. coli.

Authors:  R A Bortolussi; B Bjorkstein; P G Quie
Journal:  J Pediatr       Date:  1977-09       Impact factor: 4.406

3.  Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

Authors:  J B Robbins; G H McCracken; E C Gotschlich; F Orskov; I Orskov; L A Hanson
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

4.  Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection.

Authors:  B Kaijser
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

5.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

6.  Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.

Authors:  B Björkstén; R Bortolussi; L Gothefors; P G Quie
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

7.  Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children.

Authors:  G Lidin-Janson; E Falsen; U Jodal; B Kaijser; K Lincoln
Journal:  J Med Microbiol       Date:  1977-08       Impact factor: 2.472

8.  Epidemiology of Escherichia coli K1 in healthy and diseased newborns.

Authors:  L D Sarff; G H McCracken; M S Schiffer; M P Glode; J B Robbins; I Orskov; F Orskov
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

9.  Frequency of E. coli K antigens in urinary-tract infections in children.

Authors:  B Kaijser; L A Hanson; U Jodal; G Lidin-Janson; J B Robbins
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

10.  The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections.

Authors:  S Olling; L A Hanson; J Holmgren; U Jodal; K Lincoln; U Lindberg
Journal:  Infection       Date:  1973       Impact factor: 3.553

View more
  23 in total

1.  Production of cytotoxic necrotizing factor, verocytotoxin and haemolysin by pyelonephritogenic Escherichia coli.

Authors:  A Brauner; M Katouli; K Tullus; S H Jacobson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

Review 2.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

3.  CHANGES IN URINARY ISOLATES AND THEIR ANTIBIOTIC RESISTANCE PATTERN.

Authors:  R N Misra; N K Debata; Yogesh Chander; V C Ohri
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Attachment of bacteria to mammalian surfaces.

Authors:  B Sugarman
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Escherichia coli K1 in urinary tract infections.

Authors:  J Reina; F Salva; J Gil; P Alomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

6.  Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli.

Authors:  C Hughes; J Hacker; A Roberts; W Goebel
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

Review 7.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

8.  Interaction of Escherichia coli with different fimbriae and polymorphonuclear leukocytes.

Authors:  B Björkstén; T Wadström
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  P-fimbriated clones among uropathogenic Escherichia coli strains.

Authors:  V Väisänen-Rhen; J Elo; E Väisänen; A Siitonen; I Orskov; F Orskov; S B Svenson; P H Mäkelä; T K Korhonen
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Nucleotide sequence analysis of the complement resistance gene from plasmid R100.

Authors:  R T Ogata; C Winters; R P Levine
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.